Diabetes Mellitus: a Complete Ancient and Modern Historical Perspective

Total Page:16

File Type:pdf, Size:1020Kb

Diabetes Mellitus: a Complete Ancient and Modern Historical Perspective Article ID: WMC004831 ISSN 2046-1690 Diabetes mellitus: a complete ancient and modern historical perspective Peer review status: Yes Corresponding Author: Dr. Chukwuemeka Nwaneri, Visiting Senior Lecturer, Community & Child Health, University of Chester, Riverside Campus, CH11SL - United Kingdom Submitting Author: Dr. Chukwuemeka Nwaneri, Visiting Senior Lecturer, Community & Child Health, University of Chester, Riverside Campus, CH11SL - United Kingdom Article ID: WMC004831 Article Type: Review articles Submitted on:15-Feb-2015, 10:48:54 PM GMT Published on: 17-Feb-2015, 10:12:38 AM GMT Article URL: http://www.webmedcentral.com/article_view/4831 Subject Categories:Diabetes Keywords:type 1 diabetes, type 2 diabetes, insulin, metformin, insulin resistance, glucose tolerance How to cite the article:Nwaneri C. Diabetes mellitus: a complete ancient and modern historical perspective. WebmedCentral Diabetes 2015;6(2):WMC004831 Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Source(s) of Funding: Nil Competing Interests: Nil WebmedCentral Peer Reviewed: Yes Webmedcentral > Review articles Page 1 of 28 WMC004831 Downloaded from http://www.webmedcentral.com on 27-Mar-2015, 10:10:37 AM Diabetes mellitus: a complete ancient and modern historical perspective Author(s): Nwaneri C Abstract diabetes medicine and health. An attempt is made in this study to produce a chronologically organised, engrossing and multi-dimensional account of diverse documented work in diabetes. An in-depth review of Diabetes mellitus is one of medical conditions that the historical timeline of diabetes shows that diabetes have been extensively investigated. Despite these has evolved over six era: era of recognition of disease, enormous developments cure for diabetes still remains description of causes, clinical diagnosis, biochemical virtual. The history is backdated to the Egyptian development and advancement and millennium antiquity. As the history became unravelled with developments. regard to the pathophysiological and biochemical bases, medical and surgical treatments and other Discussions management strategies, roadmap towards achieving success in curbing the menace of diabetes is st promising. It is only in the 21 century that diabetes Ancient time (era of recognition of disease) has been considered a chronic and heterogenous The first recognition of what came to be known as DM endocrine disorder which requires interdisciplinary and was documented in the Egyptian ancient papyrus, multidisciplinary approaches in its management, with discovered by Georg Ebers in 1862, dating back to the role of genetics looking exciting. However, there 1550 BC which highlighted the first documented cases are lots of lessons to be learnt from the past. This of DM over 3500 years ago as stated by Ebbell, in review aims to explore the timeline of diabetes journey, 1937 and Tattersall in 2010. In this chronological and and correct the inconsistencies in the historical hieroglyphically written document of compendium of perspectives of diabetes with intent to project the medical literature from 3000 BC, was noted ‘to future. regulate………excessive urine’ in 1552 BC by Introduction Hesy-Ra, an Egyptian physician. Although this may as well represent the first recognition of diabetes, medical historians believe that the first attempt at describing Diabetes mellitus (DM) has been described as a the symptoms of diabetes was made by Aulus ‘silent’ epidemic. Its presentation can either be a slow Cornelius Celsus (30 BC-50 AD) of Greece (Medvei onset and asymptomatic progression leading to 1993, Southgate 1999, Zajac et al. 2010). Celsus had secondary complications, or rapidly emerging described an ailment which presented with excessive symptoms leading to complications and/or coma. The urination in frequency and volume, and painless projection is that by year 2030, an estimated 366-438 emaciations. Apollonius Memphites, an Egyptian million (i.e., 7.8% of the world population) people will physician at around 230 BC had used the prefix have diabetes, an increase of 54% compared to that ‘diabetes’ for the first time to denote an excessive predicted in 2010 (Wild et al. 2004, Whiting et al. passage of urine and ascribed its aetiology to the 2011). After the recognition of diabetes by the kidney (Papaspyros 1964). At that time, due to lack of Egyptians, various attempts were made to understand evidence, treatment had involved dehydration and the heterogenous nature of the disease, phlebotomy (bloodletting) as a method of treatment pathophysiological mechanisms, appropriate therapies (Papaspyros 1964, Zajac et al. 2010). In about 500 BC, and prevention strategies. As part of seeking for two Hindu-Indian physicians (Chakrat & Sushrut) answers to intriguing questions in diabetes, some recognised that DM was not a single disorder, and authors were more descriptive, analytic or pessimistic they made observations of the sweetness of urine rather than scientific in their search. Developmental from observing ants congregating around the urine of milestones in diabetes reflect improvements in the patients (Tattersall 2010). Although relatively understanding and management of the condition. The uncommon, as time went on, the recognition and overview of the history of diabetes, starting from the identification of diabetes became apparent. The ancient time to the present millennium helps to concept of nature showed varying and intriguing showcase the advances that have been made in debates and revisions. Webmedcentral > Review articles Page 2 of 28 WMC004831 Downloaded from http://www.webmedcentral.com on 27-Mar-2015, 10:10:37 AM 1st century (era of description of causes) Avicenna 1991). He had suggested that diabetes was Diabetes, a Greek word was the term used to denote ‘ a disorder of the nervous system in concert with run through or siphon’ in the description of incessant interplay of liver dysfunction. In a quest for treatment, urination (Adams 1856), a word originally ascribed to Avicenna prescribed the use of emetics and exercises Demetrios of Apamaia in the 200-250 BC. However, at to alleviate the symptoms, and discouraged the use of a time, medical historians believed that Aretaeus of diuretics (Savona-Ventura 2002). The first Cappadocia (81-138 AD), a Greek physician documented evidence of diabetes in English literature re-introduced the prefix ‘diabetes’ to describe the was the use of the word ‘diabete’, purported to be wasting disease from excessive urination (Leopold, written around 1425. Following these early records no 1930). In his manuscript, Aretaeus narrated what his further progress was seen until the sixteenth century. knowledge of origin of diabetes was: 16th-18th century (era of clinical diagnosis) "The disease appears to me to have got the name of As different researchers in Egypt, Persia, China, India, diabetes, as if from the Greek word διαβητης (which Greece, Japan and Korea searched for appropriate signifies a wine-pourer or siphon) because the fluid treatments of the strange and poorly understood does not remain in the body, but uses the man’s body disease, European medical literature showed no as a ladder (διαβαθρη) whereby to leave it” (Adams evidence of any documentation of the disease. In the 1856). middle part of the 16th century, Paracelsus Aretaeus went further to describe the features of (1493-1541), a Swiss German physician, was diabetes as pragmatic in his experimental search for the pathogenesis of diabetes. He was the first to depart “a dreadful affliction being a melting down of the flesh from the Galenic approach to medical conditions. and limbs into urine. The patients never stop making Paracelsus had evaporated urine samples from people water but the flow is incessant as if from the opening with diabetes with resultant production of solutes of adequeducts….and patient is short lived” (Tattersall, (Schadewaldt 1977). However, he did not taste it but 2010, p.3 citing Papaspyros, 1952). called it ‘salts’. In his conclusion, he stated that This describes the clinical picture of type 1 DM diabetes was as a result of the deposition of salts in (T1DM). Aretaeus also distinguished polyuria of DM the kidneys. The findings made him and other from diabetes inspidus, a disease in which the kidneys researchers believed that salts were the cause of are unable to conserve water. A Greek physician, excessive urination and thirst seen in these people. Claudius Galenus, referred to as Galen (129-200 AD) During the period of recognition of sweetiness of urine supported the work of Apollonius of Memphis, by from people with diabetes, Thomas Sydenham attributing the pathology to the kidneys because of the (1624-1689) proposed that ‘chyle’ from food was not diuretic effect (Eknoyan & Nagy 2005) and called it ‘ completely digested with excretion of the diarrhoea of urine’ [diarrhoea urinosa] (Zajac et al. non-absorbable residue. He concluded that this 2010). From China in 200 AD, Tchang Tchong-King diabetes was a systemic disease as a consequence of described the excessive eating symptoms seen in this process (Farmer 1952). In 1674, Thomas Willis, these people with diabetes. The triad of polydipsia, an Oxford-trained British physician (1621-1675), polyphagia and polyuria was noted in the literature as re-echoed the presence of sweet substance in the the characteristic features
Recommended publications
  • A History of Diabetes NYSNA Continuing Education the New
    A History of Diabetes NYSNA Continuing Education The New York State Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This course has been awarded 1.2 contact hours. All American Nurses Credentialing Center (ANCC) accredited organizations' contact hours are recognized by all other ANCC accredited organizations. Most states with mandatory continuing education requirements recognize the ANCC accreditation/approval system. Questions about the acceptance of ANCC contact hours to meet mandatory regulations should be directed to the Professional licensing board within that state. NYSNA has been granted provider status by the Florida State Board of Nursing as a provider of continuing education in nursing (Provider number 50-1437). A History of Diabetes 1 © 2004 NYSNA, all rights reserved. Material may not be reproduced without written permission. How to Take This Course Please take a look at the steps below; these will help you to progress through the course material, complete the course examination and receive your certificate of completion. 1. REVIEW THE OBJECTIVES The objectives provide an overview of the entire course and identify what information will be focused on. Objectives are stated in terms of what you, the learner, will know or be able to do upon successful completion of the course. They let you know what you should expect to learn by taking a particular course and can help focus your study. 2. STUDY EACH SECTION IN ORDER Keep your learning "programmed" by reviewing the materials in order. This will help you understand the sections that follow.
    [Show full text]
  • Selected Records Related to A.C. Cuza and the National Christian Party RG-25.059M
    Selected records related to A.C. Cuza and the National Christian Party RG-25.059M United States Holocaust Memorial Museum Archives 100 Raoul Wallenberg Place SW Washington, DC 20024-2126 Tel. (202) 479-9717 e-mail: [email protected] Descriptive summary Title: Selected records related to A.C. Cuza and the National Christian Party Dates: 1834-1948 (inclusive) 1934-1943 (bulk) Accession number: 2009.267 Creator: Partidul Naţional Creştin. Liga Apărării Naţional Creştine Extent: 7,535 digital images 7 microfilm reels (digitized) Repository: United States Holocaust Memorial Museum Archives, 100 Raoul Wallenberg Place SW, Washington, DC 20024-2126 Languages: Romanian Scope and content of collection Contains records relating to A. C. Cuza, a leading anti-Semite in Romania and the leader of the National Christian Party (PNC) which was in power December 1937 to February 1938. Also contains records relating to Istrate Micescu, the Justice Minister of the PNC administration. Administrative Information Restrictions on access: No restrictions on access. Restrictions on reproduction and use: Restrictions on use. Fair use only. Use only for scientific purposes (not for commercial use) Preferred citation: Preferred citation for USHMM archival collections; consult the USHMM website for guidance. Acquisition information: Source of acquisition is the Arhivele Naţionale ale României (Romanian National Archives), Fond personal A.C. Cuza (inv. 1139) and Fond personal Istrate Miscescu. The United States Holocaust Memorial Museum Archives received the collection via the United States Holocaust Memorial Museum International Archives Program in November, 2009. Existence and location of originals: Arhivele Naţionale ale României Historical note The National-Christian Defense League (Romanian: Liga Apararii National Crestine or LANC) was a virulently anti-Semitic political party of Romania formed by A.
    [Show full text]
  • 100858 AVANCES 26 5Indd
    avances en Diabetología Av Diabetol. 2010;26:373-82 Historical perspective From pancreatic extracts to artificial pancreas: history, science and controversies about the discovery of the pancreatic antidiabetic hormone V: The controversy. Who discovered insulin? A. de Leiva-Pérez1, E. Brugués-Brugués1,2, A. de Leiva-Hidalgo1,2,3,4 1Fundación DIABEM. 2Servicio de Endocrinología y Nutrición e Instituto de Investigación. Hospital de la Santa Creu i Sant Pau. Barcelona. 3Centro de Historia de la Ciencia. Universitat Autònoma de Barcelona. 4CIBER-BBN-ISCIII The Nobel Prize controversy were provided by two members of the objection was to making an award on “he- The 1923 Nobel Award Nobel Committee: John Sjöqvist, Profes- resy evidence” from unknown persons or of Physiology or Medicine sor of Chemistry and Pharmacy, and Hans on statements in the two appraisals, like In April 1923, a total of 57 nominations Christian Jacobaeus, Professor of Internal “it is beyond doubt”, or comments as with merits were reviewed by the Nobel Medicine. Sjökvist arrived to the same ”things that are thought as very possible”; Committee. The examiners concluded conclusion as A. Krogh: the prize should the Assembly should take only verifi able that the discovery of insulin was of funda- be divided between Banting and Macleod. facts. The Committee reconsidered and mental importance. The archives of the Professor Göran Liljstrand was the Secre- reconfirmed its previous recommenda- Karolinska Institute depict that Macleod tary of the Nobel Committee from 1918 to tion. August Krogh was identifi ed as the and Banting were nominated for the fi rst 1960. He was a great friend of August source of the “heresy evidence”; he time in 1923: Banting by G.W.
    [Show full text]
  • Editorial in October, 19, 2009 Paulescu Triumphed in Canada
    Editorial In October, 19, 2009 Paulescu Triumphed in Canada When, in 1996, I published – in the group involved in the events related to the Genesis Printing House – the monograph great discovery (Banting died in 1941, entitled “Insulin – the medical discovery of MacLeod died in 1935 and Collip In 1965) – the century belongs to the Romanian .C. the publication of the famous monograph Paulescu” – I was convinced that the truth entitled “ Discovery of Insulin ” could finally be included in this quite lengthy title could not be published; it was authored by the Canadian mystified for an indefinite period of time. At histotian Michael Bliss. the time 75 years had already elapsed since the The paper – that laid emphasis on, and great event, which was correctly related to the gave details concerning the events that had year 1921, took place, but which – according taken place in Canada – had simply wiped to circumstances and subjective preferences – away the myth according to which Banting was incorrectly attributed to either Banting and Best were the discoverers of insulin. The and Best (as it appeared in certain medical great part of the merit in the discovery of treaties) or to Banting and MacLeod (as it insulin was now attributed to the other two appeared in other treaties that mentioned the members of the Canadian group MacLeod and names of those who, in 1923, unfairly Collip. A myth died another myth was born – received the Nobel Prize for the discovery a myth closer to reality, but one that could not made by Paulescu). definitely be separated from the Toronto In 1996 the Canadians organized in events.
    [Show full text]
  • The Discovery of Insulin
    Diabetes Frederick Banting and Charles Best purified the hormone • 1996: The introduction of insulin analogues with higher The Discovery of Insulin: The Ultimate Key insulin from bovine pancreases and administered it to and improved Absorption, Distribution, Metabolism and a first patient in 1922. The result was an elimination of Excretion (ADME). glycosuria (glucose in the urine) and a 77% drop of • 2005: FDA approves a new drug for type 2 Diabetes to Uncovering the Secret of Diabetes glycaemia (glucose in the blood) for the patient. derived from the Gila monster. Exendin4, found in the venom of the lizard triggers one of the insulin- releasing By the fall of 1923, 25000 patients were treated with pathways. Dr. Alice Gerges Geagea insulin injections in Canada and the United States. Banting • 2008: Suzanna M. de la Monte proposes the term “ type 3 received a Noble prize for this breakthrough and World diabetes ” to describe insulin resistance in the brain. PharmD, PhD, MSc Public Health Diabetes Day is now being celebrated worldwide on • 2013: The University of Cambridge trials an artificial November 14 which coincides with Banting’sbirthday. pancreas which combines the technology of an insulin It is well established that diabetes mellitus is a chronic pump with a continuous glucose monitor. disease caused by inherited and/or acquired deficiency in Other important landmark discoveries can be cited such • 2015: Dr Edward Damiano introduces the iLet , a bionic production of insulin by the pancreas or the ineffectiveness as: pancreas that delivers both insulin and glucagon every of the insulin produced. Such a deficiency results in • 1922: Development of Metformin which is now, among five minutes.
    [Show full text]
  • The Main Events in the History of Diabetes Mellitus
    Chapter 1 The Main Events in the History of Diabetes Mellitus Jacek Zajac, Anil Shrestha, Parini Patel, and Leonid Poretsky In Antiquity A medical condition producing excessive thirst, continuous urination, and severe weight loss has interested medical authors for over three millennia. Unfortunately, until the early part of twentieth century the prognosis for a patient with this condition was no better than it was over 3000 years ago. Since the ancient physicians described almost exclusively cases of what is today known as type 1 diabetes mellitus, the outcome was invariably fatal. Ebers Papyrus, which was written around 1500 BC, excavated in 1862 AD from an ancient grave in Thebes, Egypt, and published by Egyptologist Georg Ebers in 1874, describes, among various other ailments and their remedies, a condition of “too great emptying of the urine” – perhaps, the reference to diabetes mellitus. For the treatment of this condition, ancient Egyptian physicians were advocating the use of wheat grains, fruit, and sweet beer.1,2 Physicians in India at around the same time developed what can be described as the first clinical test for dia- betes. They observed that the urine from people with diabetes attracted ants and flies. They named the condition “madhumeha” or “honey urine.” Indian physicians also noted that patients with “madhumeha” suffered from extreme thirst and foul breath (probably, because of ketosis). Although the polyuria associated with diabetes was well recognized, ancient clinicians could not distinguish between the polyuria due to what we now call diabetes mellitus from the polyuria due to other conditions.3 Around 230 BC, Apollonius of Memphis for the first time used the term “diabetes,” which in Greek means “to pass through” (dia – through, betes – to go).
    [Show full text]
  • THE DISCOVERY of INSULIN and NICOLAE PAULESCU
    1 THE DISCOVERY OF INSULIN and NICOLAE PAULESCU F. I. Dworschak 2 : I have tried not to be offensive and you may think I have been too mild, but I know that any criticism of the Toronto workers will be regarded as almost sacrilegious in certain quarters.” Ian Murray to I. Pavel, 4 April 1970 “He (Paulescu) was the first to describe the actions of what was later called insulin and demonstrated clearly that it was a hormone with actions on all aspects of metabolism”. Sir George Al berti December 2001 3 INTRODUCTION This essay will re-examine the contributions to insulin research and other areas of Medicine and Physiology by Nicolae Constantin Paulescu and account for his relative lack of recognition in English language historiography. 1 One important reason was that he wrote and published exclusively in French. He also had little access to English language medical publications, likely because he could not afford them (see his unanswered letter to Banting dated 5 February 1923). As such, he was out of touch with the rapid advances in diabetes research in the Anglo-Saxon medical literature, relying exclusively on French sources. Starting in 1922 this became fatal, he was left behind and his contributions, meager at this stage also due to financial problems, became almost irrelevant. This is in marked contrast to the previous years (1920-1921) when one could rightly say that he was the leading researcher investigating the whole range of physiological properties of the “inner secretion” of the pancreas that eventually would be known as insulin. Viewed from this angle he should be considered the discoverer of insulin as a hormone affecting practically all aspects of the metabolism.
    [Show full text]
  • Cv. Prof. Dr. Gabriela Roman
    Curriculum vitae Europass Nume / Prenume ROMAN GABRIELA Adresă(e) nr.29, str. Baia-Mare, cod poştal 400171, Cluj-Napoca, Romania Telefon(oane) Fix: 0264 432 640 Mobil: 0728097507 Fax(uri) 0264 59 44 55 E-mail(uri) Serviciu: [email protected] Personal: [email protected] Naţionalitate(-tăţi) română Data naşterii Sex F Locul de muncă vizat / Universitatea de Medicina si Farmacie „Iuliu Hatieganu” Cluj-Napoca Spitalul Clinic Judetean de Urgenta – Centrul de Diabet, Nutritie, Boli metabolice Domeniul ocupaţional Medicină – Disciplina Diabet şi Boli de nutriţie Experienţa profesională Perioada 1.11. 2017 Funcţia sau postul ocupat – Sef Sectie - Centrul de Diabet, Nutritie, Boli metabolice Perioada 1.10.2016 – Funcţia sau postul ocupat Profesor Sef disciplină Diabet, Nutriţie, Boli metabolice 2011 – prezent Membru Consiliul Departament 6 – Specialități medicale Numele şi adresa angajatorului Universitatea de Medicină şi Farmacie „Iuliu Haţieganu” Cluj-Napoca, Facultatea de Medicină, Catedra de Diabet şi Boli de nutriţie, str. Clinicilor 2-4, cod poştal 400006, Website: www.umfcluj.ro Educaţie şi formare Perioada 2004 Calificarea / diploma obţinută Titlul de Doctor în Medicină, Universitatea de Medicină şi Farmacie “Iuliu Haţieganu”, Teza de Doctorat: „Educaţia structurată în Sindromul X metabolic”, conf. OMEC nr. 3876 / 19.05. 2004, Seria Numele şi tipul instituţiei de învăţământ C, nr. 0005361, Nr. 713 / 23.11.2004 / furnizorului de formare Ministerul Educaţiei şi Cercetării Perioada 2000 Calificarea / diploma obţinută Diplomă medic primar, specialitatea diabet, nutriţie, boli metabolice, conf. Ord. NS OMS, nr. 727 / 7.09. 2000 Numele şi tipul instituţiei de Ministerul Sănătăţii învăţământ / furnizorului de formare Perioada 1999 (Mai – Septembrie) Calificarea / diploma obţinută Bursă de studii doctorale – Program Socrates Erasmus, Londra, Marea Britanie Numele şi tipul instituţiei de Royal London Hospital; St.
    [Show full text]
  • Health Plan Insights
    Health Plan Insights August 2020 Updates from July 2020 800.361.4542 | envisionrx.com Confidential - Document has confidential information and may not be copied, published or distributed, in whole or in part, in any form or medium, without EnvisionRxOptions’ prior written consent. Recent FDA Approvals New Medications TRADE NAME DOSAGE FORM APPROVAL MANUFACTURER INDICATION(S) (generic name) STRENGTH DATE ByfavoTM Acacia Pharma, Injection, for IV use For the induction and maintenance of procedural July 2, 2020 (remimazolam) Inc. Eq 20 mg/vial sedation in adults undergoing procedures lasting 30 minutes or less. RukobiaTM ViiV Healthcare Extended-Release For use in combination with other antiretroviral(s), July 2, 2020 (fostemsavir) Tablets, for the treatment of HIV-1 infection in heavily 600 mg treatment-experienced adults with multidrug- resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations. QwoTM Endo Aesthetics Injection for SQ For the treatment of moderate to severe cellulite July 6, 2020 (collagenase LLC use, in the buttocks of adult women. clostridium 0.92 mg and 1.84 histolyticum-aaes) mg Hulio® Mylan Injection for SQ For the treatment of Rheumatoid Arthritis, July 6, 2020 (adalimumab-fkjp) Pharmaceuticals use, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Inc. 40 mg/0.8 mL and Ankylosing Spondylitis, Adult Crohn’s Disease, 20 mg/0.4 mL Ulcerative Colitis, and Plaque Psoriasis. Inqovi® Otsuka Tablets, For the treatment of adult patients with July 7, 2020 (decitabine and Pharmaceutical 35 mg/100 mg myelodysplastic syndromes (MDS), including cedazuridine) Company, Ltd. previously treated and untreated, de novo and secondary MDS with the following FrenchAmerican-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
    [Show full text]
  • Banting and Best: the Extraordinary Discovery of Insulin
    106 Rev Port Endocrinol Diabetes Metab. 2017;12(1):106-115 Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo www.spedmjournal.com Artigo de Revisão Banting and Best: The Extraordinary Discovery of Insulin Luís Cardosoa,b, Dírcea Rodriguesa,b, Leonor Gomesa,b, Francisco Carrilhoa a Department of Endocrinology, Diabetes, and Metabolism, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal b Faculty of Medicine of the University of Coimbra, Coimbra, Portugal INFORMAÇÃO SOBRE O ARTIGO ABSTRACT Historial do artigo: Diabetes was a feared disease that most certainly led to death before insulin discovery. During the first Recebido a XX de XXXX de 201X two decades of the 20th century, several researchers tested pancreatic extracts, but most of them caused Aceite a XX de XXXX de 201X Online a 30 de junho de 2017 toxic reactions impeding human use. On May 1921, Banting, a young surgeon, and Best, a master’s student, started testing the hypothesis that, by ligating the pancreatic ducts to induce atrophy of the exocrine pancreas and minimizing the effect of digestive enzymes, it would be possible to isolate the Keywords: internal secretion of the pancreas. The research took place at the Department of Physiology of the Diabetes Mellitus University of Toronto under supervision of the notorious physiologist John MacLeod. Banting and Insulin/history Best felt several difficulties depancreatising dogs and a couple of weeks after the experiments had Pancreatic Extracts/history begun most of the dogs initially allocated to the project had succumbed to perioperative complications. When they had depancreatised dogs available, they moved to the next phase of the project and prepared pancreatic extracts from ligated atrophied pancreas.
    [Show full text]
  • Fructosamine Is a Valuable Marker for Glycemic Control And
    www.nature.com/scientificreports OPEN Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation Noam Shohat1,2, Karan Goswami1, Leigham Breckenridge1, Michael B. Held3, Arthur L. Malkani4, Roshan P. Shah3, Ran Schwarzkopf5 & Javad Parvizi1* Recently, fructosamine has shown promising results in predicting adverse outcomes following total knee arthroplasty. The purpose of this study was to assess the utility of fructosamine to predict adverse outcomes following total hip arthroplasty (THA). A prospective multi‑center study involving four institutions was conducted. All primary THA were evaluated for glycemic control using fructosamine levels prior to surgery. Adverse outcomes were assessed at a minimum 1 year from surgery. Primary outcome of interest was periprosthetic joint infection (PJI) based on the International Consensus Meeting (ICM) criteria. Secondary outcomes assessed were superfcial infections, readmissions and death. Based on previous studies on the subject, fructosamine levels above 293 µmol/L were used to defne inadequate glycemic control. Overall 1212 patients were enrolled in the present study and were available for follow up at a minimum 1 year from surgery. Of those, 54 patients (4.5%) had elevated fructosamine levels (> 293 µmol/L) and these patients were 6.7 times more likely to develop PJI compared to patients with fructosamine levels below 293 µmol/L (p = 0.002). Patients with elevated fructosamine were also associated with more readmissions (16.7% vs. 4.4%, p < 0.007) and a higher mortality rate (3.7% vs. 0.6%, p = 0.057). These associations remained statistically signifcant in a multi‑regression analysis after adjusting for age, comorbidities and length of stay; Adjusted odds ratio were 6.37 (95% confdence interval 1.98–20.49, p = 0.002) for PJI and 2.68 (95% confdence interval 1.14–6.29, p = 0.023) for readmissions.
    [Show full text]
  • Living with Diabetes
    Living with Diabetes A Self-Care Manual Diabetes Education: 425-339-5431 everettclinic.com Diabetes Education Table of Contents About the Diabetes Education Program ......................... 1 About Diabetes Definition& Explanation .............................................. 2 Types of Diabetes ........................................................ 4 Diagnosing or Discovering Diabetes ............................... 5 Feelings & Concerns about Having Diabetes ................... 6 Diabetes Care Controlling Your Diabetes & Care Guidelines .................. 7 Consequences of Untreated Diabetes ............................ 8 Managing Sick Days .................................................... 9 Resources Diabetes Resources ................................................... 10 Nutrition Basic Guidelines & Meal Planning .............................. 11 Diabetes Food Serving Guide ...................................... 12 Sample Meal Plan ..................................................... 13 Blood Glucose A Balancing Act ........................................................ 14 Tracking your Blood Glucose / Home Monitoring ........... 15 Low Blood Sugar (Hypoglycemia) ................................ 17 High Blood Sugar (Hyperglycemia) .............................. 19 Weight Loss ' Exercise Weight Loss Guidelines .............................................. 20 Guidelines for Exercise .............................................. 21 Preventing Complications Taking Care of Your Eyes ...........................................
    [Show full text]